NCNA
NuCana PLC
NASDAQ: NCNA · HEALTHCARE · BIOTECHNOLOGY
$2.13
+4.41% today
Updated 2026-04-30
Market cap
$9.20M
P/E ratio
0.00
P/S ratio
—
EPS (TTM)
$0.00
Dividend yield
—
52W range
$1 – $250
Volume
0.0M
NuCana PLC (NCNA) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-5.25M | $-4.47M | $-9.26M | $-8.71M | $-12.22M | $-23.83M | $-21.62M | $-23.82M | $-23.16M | $-26.44M | $-19.12M | $-6.96M |
| Capital expenditures | $15946.00 | $396000.00 | $554000.00 | $1.09M | $1.62M | $1.26M | $1.63M | $1.06M | $518000.00 | $478000.00 | $293000.00 | $193000.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $1.55M | $785000.00 | $1.13M | $11.73M | $1.79M | $3.23M | $4.30M | $6.66M | $4.89M | $3.86M | $1.65M | $10.03M |
| Free cash flow | $-5.26M | $-4.86M | $-9.82M | $-9.80M | $-13.85M | $-25.09M | $-23.25M | $-24.89M | $-23.68M | $-26.92M | $-19.41M | $-7.15M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | — | — | — |